Beyond the Pill: New Brain Tech Offers Hope for Mental Wellness

MONUMENT, Colo. – April 30, 2026 – As the conversation around mental health expands beyond traditional treatments, a local medical practice is introducing a non-invasive technology that uses magnetic energy to support brain health. Glover Family Medicine announced this week it is launching EXOMIND, an FDA-cleared brain stimulation device, offering a new pathway for patients grappling with depression, anxiety, and other mental wellness challenges.

The move, announced ahead of May's Mental Health Awareness Month, signals a broader shift in healthcare toward integrating advanced, medication-free options into patient care. Glover Family Medicine will showcase the technology at a complimentary "Brain Brunch" on May 12, providing a firsthand look at what could be the next frontier in mental and cognitive support.

The Science of Magnetic Stimulation

At the core of EXOMIND is a form of transcranial magnetic stimulation (TMS), a technology that has been gaining traction in psychiatric and neurological fields for years. The procedure is non-invasive and requires no anesthesia. During a session, which lasts under 30 minutes, an applicator is placed on the patient's head, delivering targeted magnetic pulses to specific areas of the brain that regulate mood, cognitive function, and emotional control.

"Patients are increasingly seeking alternatives to medication that support how they feel, think and function day to day," said Dr. Jamie Glover, the board-certified family physician who founded the practice. "EXOMIND offers a noninvasive solution that can support mental wellness and brain health, helping patients improve sleep, focus, resilience and emotional balance, while also serving as an option for individuals dealing with depression, anxiety and OCD."

Manufactured by BTL, a global company known for its medical and aesthetic devices, EXOMIND is FDA-cleared in the United States for the treatment of depression. While the underlying TMS technology has a well-established record for safety and efficacy, the specific device's broader claims for general wellness are still under investigation through several registered clinical trials. This distinction is important; FDA clearance signifies a device is substantially equivalent to an existing one, a different standard than the rigorous clinical trials required for full FDA approval for specific medical conditions. However, the technology is part of a rapidly growing market for non-invasive brain stimulation systems, projected to exceed $1.4 billion globally by next year, driven by the rising prevalence of neurological disorders and a strong patient desire for drug-free interventions.

A Physician's Mission Meets a Modern Care Model

The decision to incorporate this technology is deeply rooted in Dr. Glover's professional experience. Her background as a former U.S. Air Force physician exposed her to the profound mental health needs of service members, particularly those facing post-traumatic stress disorder (PTSD).

"As a former U.S. Air Force physician, I've cared for many veterans facing PTSD and recognized the need for additional, medication-free options," Dr. Glover stated. "EXOMIND offers another pathway for patients."

This mission is amplified by the unique structure of her practice. Glover Family Medicine operates on a Direct Primary Care (DPC) model, a membership-based system that bypasses traditional insurance billing for primary care services. This approach fosters a more direct and personal relationship between doctor and patient, allowing for longer appointments and a focus on holistic, preventative care. By integrating an advanced, cash-pay service like EXOMIND, the practice can offer innovative treatments that might not be accessible or covered under conventional insurance plans. This flexibility allows the DPC model to evolve, blending foundational primary care with cutting-edge wellness technologies. While primary care is for members, the practice is making EXOMIND consultations and treatments available to the wider community, regardless of membership status.

Reported Outcomes and Community Introduction

Patients who undergo the recommended treatment course—typically two sessions per week for three to six weeks—report a range of positive effects. Commonly cited improvements include enhanced mood, better mental clarity, deeper sleep, and a greater capacity to handle stress. Some individuals have also noted ancillary benefits such as reduced food cravings, which can contribute to weight loss.

To give the Monument community a chance to learn more, Glover Family Medicine is hosting its "Brain Brunch" on Tuesday, May 12, from 11:30 a.m. to 2:30 p.m. at their office located at 1840 Deer Creek Road. The open house event will feature physician-led presentations, live demonstrations of the EXOMIND technology, and informational sessions at 11:30 a.m., 12:30 p.m., and 1:30 p.m. Attendees will also be eligible for a 15% discount on EXOMIND wellness packages purchased during the event. Interested parties are encouraged to RSVP for the free event through Eventbrite or by calling the office directly.